Solara Active Pharma Sciences Approves Allotment of 8,300 Equity Shares Under ESOP
Solara Active Pharma Sciences Ltd 路 Others (Uncategorized) 路 16 Oct 2026, 7:13 pm
Solara Active Pharma Sciences Approves Allotment of 8,300 Equity Shares Under ESOP Solara Active Pharma Sciences approved the allotment of 8,300 fully paid-up equity shares of face value Rs 10 each on 16th Oct'26 pursuant to the exercise of vested options under its Employee Stock Option Plan 2018. Issued at an exercise price of Rs 375 per share (including a premium of Rs 365), the company realized Rs 31,12,500 from the exercise. Following this allotment, the company's total paid-up equity capital increased to Rs 48,16,99,569 comprising 4,82,58,812 shares, with post-issue diluted EPS reported at Rs 6.16.
Original exchange filing (PDF)
More announcements from Solara Active Pharma Sciences Ltd
- Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 2026 路 23 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding the dispatch of Final Reminder -cum-Forfeiture Notice for the payment of outstanding call money to the holders .... 路 18 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 路 17 Oct 2026
- Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 2026 路 17 Oct 2026
- Solara Active Pharma Sciences Limited has informed the exchange about the Statement of Deviation/Variation in utilization of funds raised though Rights issue for the quarter ended September 30 2026 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 470000 options under Solara Employee Stock Option Plan 2024 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated October 16, 2026, titled "Solara''s Q2 FY 27 revenue grows 33% to INR 4,178 Mn and EBITDA .... 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter .... 路 16 Oct 2026
